DK0655247T3 - Anvendelse af vinkristin til bestemmelse af substanser på neuralt niveau - Google Patents

Anvendelse af vinkristin til bestemmelse af substanser på neuralt niveau

Info

Publication number
DK0655247T3
DK0655247T3 DK94403014T DK94403014T DK0655247T3 DK 0655247 T3 DK0655247 T3 DK 0655247T3 DK 94403014 T DK94403014 T DK 94403014T DK 94403014 T DK94403014 T DK 94403014T DK 0655247 T3 DK0655247 T3 DK 0655247T3
Authority
DK
Denmark
Prior art keywords
substances
vincristine
determination
level
neural level
Prior art date
Application number
DK94403014T
Other languages
English (en)
Inventor
Francois-Xavier Coude
Umberto Guzzi
Jacqueline Fournier
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK0655247T3 publication Critical patent/DK0655247T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
DK94403014T 1990-05-22 1991-05-21 Anvendelse af vinkristin til bestemmelse af substanser på neuralt niveau DK0655247T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9006399A FR2662355B1 (fr) 1990-05-22 1990-05-22 Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.

Publications (1)

Publication Number Publication Date
DK0655247T3 true DK0655247T3 (da) 2002-02-18

Family

ID=9396855

Family Applications (2)

Application Number Title Priority Date Filing Date
DK94403014T DK0655247T3 (da) 1990-05-22 1991-05-21 Anvendelse af vinkristin til bestemmelse af substanser på neuralt niveau
DK91401311.5T DK0458696T3 (da) 1990-05-22 1991-05-21 Anvendelse af 1-(2-naphtylethyl)-4-(3-trifluormethylphenyl)-1,2,3,6-tetrahydropyridin til fremstilling af et lægemiddel til behandling af cerebrale og neuronale sygdomme

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK91401311.5T DK0458696T3 (da) 1990-05-22 1991-05-21 Anvendelse af 1-(2-naphtylethyl)-4-(3-trifluormethylphenyl)-1,2,3,6-tetrahydropyridin til fremstilling af et lægemiddel til behandling af cerebrale og neuronale sygdomme

Country Status (17)

Country Link
US (3) US5229389A (da)
EP (2) EP0655247B1 (da)
JP (2) JP2618115B2 (da)
KR (1) KR0181330B1 (da)
AT (2) ATE132369T1 (da)
BR (1) BR9105015A (da)
CA (2) CA2042974C (da)
CY (1) CY2283B1 (da)
DE (2) DE69115989T2 (da)
DK (2) DK0655247T3 (da)
FR (1) FR2662355B1 (da)
HK (1) HK1001471A1 (da)
HU (1) HU208922B (da)
IE (1) IE911707A1 (da)
IL (3) IL112167A (da)
TW (1) TW216771B (da)
ZA (1) ZA913865B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0192386A (ja) * 1987-10-05 1989-04-11 Hitachi Ltd 密閉循環型吸収式冷凍機及び吸収式冷凍機用吸収液
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5618822A (en) * 1990-05-23 1997-04-08 Sanofi N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
US5557209A (en) * 1990-12-20 1996-09-17 Hewlett-Packard Company Identification of pin-open faults by capacitive coupling through the integrated circuit package
FR2690158B1 (fr) * 1992-04-17 1994-07-22 Sanofi Elf Nouveau derive arylpiperidinique, procede pour sa preparation et compositions pharmaceutiques le contenant.
FR2702656B1 (fr) * 1993-03-18 1995-06-16 Sanofi Elf Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments cardioprotecteurs.
US5698565A (en) * 1995-06-09 1997-12-16 Hoffmann-La Roche Inc. Use of phenoxy-pyridine derivatives
FR2736053B1 (fr) * 1995-06-28 1997-09-19 Sanofi Sa Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines
FR2740343B1 (fr) * 1995-10-26 1999-01-22 Sanofi Sa Utilisation de la 1-(2-napht-2-yl-ethyl)-4- (3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de la sclerose laterale amyotrophique
EP0866704B1 (fr) * 1995-10-26 2001-04-11 Sanofi-Synthelabo Utilisation de la 1-(2-napht-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de la sclerose laterale amyotrophique
JP2000507828A (ja) * 1996-03-29 2000-06-27 ザ トラスティーズ オブ ボストン ユニバーシティー アルツハイマー病の診断および治療法
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
FR2757161B1 (fr) * 1996-12-13 1999-03-12 Sanofi Sa Diphenylalkyl-tetrahydropyridines
FR2757160B1 (fr) * 1996-12-13 1999-03-12 Sanofi Sa 1-phenylalkyl-1,2,3,6-tetrahydropyridines
FR2757510B1 (fr) * 1996-12-23 2000-01-07 Sanofi Sa Forme microparticulaire d'un derive de tetrahydropyridine
FR2757512B1 (fr) * 1996-12-24 1999-03-12 Sanofi Sa Utilisation de benzoylalkyl-1-1,2,3,6-tetrahydropyridines
CZ275399A3 (cs) * 1997-02-03 1999-12-15 Sanofi-Synthelabo Použití 1-[4-(3-trifluormethylfenyl)-1,2,3,6-tetrahydropyrid-1-yl]-2-(6,7-dimethoxynaft-2-yl)ethanu pro výrobu léčiv s neurotrofní aktivitou
FR2762514B1 (fr) 1997-04-29 1999-10-22 Sanofi Sa Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
FR2771007B1 (fr) * 1997-11-14 2000-12-01 Sanofi Sa Association de principes actifs pour le traitement de la demence senile du type alzheimer
CO4980891A1 (es) * 1997-11-14 2000-11-27 Sanofi Sa Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer
DE19751949A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
TWI237035B (en) * 1998-07-24 2005-08-01 Polyplastics Co Polyacetal copolymer
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
FR2639226B1 (fr) * 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.

Also Published As

Publication number Publication date
FR2662355A1 (fr) 1991-11-29
AU7713391A (en) 1991-11-28
EP0655247B1 (fr) 2001-10-31
IL98175A (en) 1996-01-19
TW216771B (da) 1993-12-01
DE69132797T2 (de) 2002-05-29
US5270320A (en) 1993-12-14
IL112167A (en) 1996-01-31
JP2954029B2 (ja) 1999-09-27
FR2662355B1 (fr) 1994-11-10
DK0458696T3 (da) 1996-05-20
DE69115989T2 (de) 1996-08-22
EP0458696A3 (en) 1992-03-18
CA2365832C (en) 2007-08-07
HU911729D0 (en) 1991-12-30
JPH09132535A (ja) 1997-05-20
HUT59824A (en) 1992-07-28
CA2042974A1 (en) 1991-11-22
ATE132369T1 (de) 1996-01-15
ZA913865B (en) 1992-02-26
BR9105015A (pt) 1993-05-25
IL112167A0 (en) 1995-03-15
HU208922B (en) 1994-02-28
CY2283B1 (en) 2003-07-04
US5229389A (en) 1993-07-20
IL98175A0 (en) 1992-06-21
CA2042974C (en) 2002-09-17
CA2365832A1 (en) 1991-11-23
DE69132797D1 (de) 2001-12-06
EP0458696B1 (fr) 1996-01-03
US5468753A (en) 1995-11-21
IE20011078A1 (en) 2002-03-20
JP2618115B2 (ja) 1997-06-11
ATE207747T1 (de) 2001-11-15
KR0181330B1 (ko) 1999-03-20
HK1001471A1 (en) 1998-06-19
IE911707A1 (en) 1991-12-04
EP0655247A1 (fr) 1995-05-31
DE69115989D1 (de) 1996-02-15
KR910019617A (ko) 1991-12-19
EP0458696A2 (fr) 1991-11-27
AU636488B2 (en) 1993-04-29
JPH04226917A (ja) 1992-08-17

Similar Documents

Publication Publication Date Title
DK0655247T3 (da) Anvendelse af vinkristin til bestemmelse af substanser på neuralt niveau
DE3177156D1 (de) Guanin-verbindungen und ihre verwendung zur herstellung eines antivirusmittels.
ATE4234T1 (de) Vorrichtung zur dosierten abgabe eines wirkstoffs.
IT8124138A0 (it) Procedimento e apparecchio per determinare quantitativamente il livello di emoglobina in campioni biologici.
DE68906545D1 (de) Verfahren zum melken eines tieres.
DE3764056D1 (de) Verfahren und vorrichtung zur aufzeichnung und/oder auswertung des bewegungsverhaltens von versuchstieren.
DE58903504D1 (de) Verfahren zur messung der konzentration optisch aktiver substanzen und anordnung zur durchfuehrung des verfahrens.
Rickson et al. Social bases of farmers' responses to land degradation.
DE68919190T2 (de) Chemischer Bodenfühler und Verfahren zur genauen Dosierung von chemischen, landwirtschaflichen Stoffen.
AT383491B (de) Vorrichtung zum verabreichen von voll- oder sitz- baedern, insbesondere unter verwendung von peloid
DE59000468D1 (de) Verfahren zur schnellen pruefung der wirksamkeit von agenzien auf mikroorganismen.
DE69107203T2 (de) Wirbelbettverfahren zum imprägnieren von fasern mit polymer-pulvern und vorrichtung dafür.
DE68910163D1 (de) Verfahren zur Bekämpfung von biologischen Verschmutzungen bei der Erdölförderung.
Salanki Behavioural studies on mussels under changing environmental conditions
ATE9343T1 (de) 2,6-diethyl-3,5-dimethyl-2,3-dihydro-4h-pyran, verfahren zu seiner herstellung und seine verwendung zur frueherkennung, lokalisierung und bekaempfung von lasioderma serricorne f.
DE69103425T2 (de) Verfahren zur verhinderung der zerstörung von meerwasserzellen durch biologische verschmutzung.
Manning River Recreation Use and Analysis of Carrying Capacity
DE59103597D1 (de) Verfahren zum ermitteln der kraftstoffeinspritzmenge.
EHLER et al. Water quality guidance: Development of residuals management strategies. An executive summary[Socioeconomic Environmental Studies Series]
DE60130488D1 (de) Verfahren zur identifizierung von ein physiologisch aktives polypeptid kodierender dna in einem nagetier
Sherwood Effects on marine life: fin erosion disease induced in the laboratory.
ATE78480T1 (de) Purin- und pyrimidin-verbindungen und deren verwendung als antivirusmittel.
MX9203737A (es) Metodo para establecer niveles de sangre de biocida en enimales y sistema de dosificacion y metodo para usar el mismo.
ES508226A0 (es) "metodo para la determinacion del nivel de transferrina en la sangre".
DE3177285T2 (de) Purin- und pyrimidin-verbindungen und deren verwendung als antivirusmittel.